# Gastroenterology Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Charles Darwin (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI003-SYN
- Date: 2026-03-03
- Fictional facility: St. Posthumous Health Center
- Fictional author: Bernard Ashworth, MD
- Calendar frame: modern shifted

- To: Mei-Ling Zhou, MD, Gastroenterology
- Urgency: Routine, within six weeks, on the same day as his results visit

## Referral question

Recurrent stereotyped episodes of nausea and vomiting for more than a year in a 40-year-old man, about every one to three weeks and almost weekly this winter. Please advise whether this is cyclic vomiting syndrome, whether the work-up is complete, and on prophylaxis, abortive treatment, and an emergency plan. **S**

## Questions for the consultant

1. Do his episodes meet the Rome IV criteria for cyclic vomiting syndrome, and is anything in the history against it?
2. Is the work-up complete, or are further tests needed (for example a gastric emptying study or brain imaging)?
3. Do you advise prophylaxis, and if so which medicine, at what dose, and with what monitoring?
4. What abortive treatment should he take at the prodrome?
5. What should an emergency department do when an episode does not settle?
6. How should his anxiety about episodes and his triggers be addressed, and how often should he be followed?

## Pertinent history

More than a year of episodes, each beginning with half an hour to an hour of nausea, sweating, trembling hands, a racing heart, and a swimming head, followed by repeated vomiting for 12 to 36 hours; he lies still in a dark room until it passes. Between episodes he has troublesome wind and tires easily but does not vomit. Episodes cluster around social gatherings, speaking to groups, overnight travel, short sleep, and long gaps without food. He has never used cannabis and has no habit of hot baths or showers during episodes. One or two glasses of wine a week; does not smoke. No weight loss, blood in vomit or stool, nocturnal pain, migraine headaches, or neurological symptoms. Past history of palpitations in his twenties. Blood count, electrolytes, creatinine, glucose, calcium, albumin, liver tests, lipase 32 U/L, TSH 1.6, morning cortisol 14.2, tissue transglutaminase IgA 1.2 with total IgA 210, and a urine dipstick all normal, drawn between episodes. ECG: sinus rhythm, QTc 412 ms. GAD-7 8 and PHQ-9 6, with no thoughts of self-harm. CT enterography and upper endoscopy ordered. Blood pressure 118/74 mmHg, pulse 78, weight 71.6 kg, BMI 21.4. No medicines. **S**

- Charles Darwin was born on February 12, 1809, in Shrewsbury, Shropshire, England. **D**
- While waiting at Plymouth to sail on the Beagle in late 1831, Darwin was troubled with palpitations and pain about the heart, and consulted no doctor for fear of being judged unfit for the voyage. **D**
- In September 1837 he had palpitations and, on his doctors' advice, went to the country to recover. **D**
- Darwin first mentioned periodical vomiting in a letter to W. D. Fox in June 1840. **D**
- In February 1849 he described incessant vomiting to Richard Owen, and in March 1849 he wrote that he had been bad all winter, with dreadful vomiting every week, that his hands trembled, and that his head was often swimming. **D**
- Over his adult life he had gastrointestinal distress, including vomiting, retching, and bowel irregularity, with headaches, fatigue, trembling, faintness, dizziness, and skin problems including eczema. **D**
- Cyclic vomiting syndrome, perhaps from a mitochondrial DNA disorder, has been proposed as the cause of his illness. **R**
- Chagas disease, contracted during the Beagle voyage, has been proposed as the cause of his illness. **R**
- Systemic lactose intolerance has been proposed as the cause of his illness. **R**
- Panic disorder with agoraphobia has been proposed as the explanation of his illness and secluded life. **R**
- Other proposed explanations include hyperventilation, neurasthenia, hypoglycemia, other allergies, Crohn's disease, Helicobacter pylori infection, systemic lupus, Meniere's disease, and psychological or psychosomatic causes. **R**

5 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: Hemoglobin: 14.6 g/dL; White blood cells: 6.4 10*3/uL; Platelets: 251 10*3/uL; Sodium: 140 mmol/L; Potassium: 4.1 mmol/L; Chloride: 103 mmol/L; Bicarbonate (total CO2): 25 mmol/L; Creatinine: 0.94 mg/dL; eGFR: 104 mL/min/1.73 m²; Glucose: 88 mg/dL; Calcium: 9.5 mg/dL; Albumin: 4.4 g/dL; ALT: 21 U/L; AST: 19 U/L; Alkaline phosphatase: 68 U/L; Total bilirubin: 0.7 mg/dL; Lipase: 32 U/L; TSH: 1.6 mIU/L; Cortisol, morning: 14.2 ug/dL; Tissue transglutaminase IgA: 1.2 U/mL; Total IgA: 210 mg/dL; QTc (ECG): 412 ms; GAD-7: 8; PHQ-9: 6. All results are synthetic.

BP 118/74 mmHg; pulse 78 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 71.6 kg; BMI 21.4 kg/m². All vital signs are synthetic.

## Current medications

- No current medications. **S**

## Plan so far

- Work-up between episodes: blood count, metabolic and liver panels, lipase, urinalysis, TSH, morning cortisol, celiac serology, a baseline ECG, CT enterography, and upper endoscopy. Guideline: Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) **S**
- Symptom diary: date, prodrome, length and severity of each episode, triggers, medicines taken, and emergency visits. Guideline: Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019) **S**
- Anxiety and mood: GAD-7 and PHQ-9 at the first visit and every three months; relaxation breathing, with cognitive behavioral therapy offered if symptoms persist. Guideline: Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association (2019); Anxiety Disorders in Adults: Screening (2023) **S**
